Highlights MINAPHARM Pharmaceuticals

Equities

MIPH

EGS380G1C011

End-of-day quote Egyptian Exchange Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
200.3 ^EGP	0.00%		0.00%	-8.00%

04-07	MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023	04-07	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/08/23	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2023	28/05/23	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2022	29/03/23	CI
Bioventure, Minapharm Pharmaceuticals and Migentra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa	30/11/22	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	28/11/22	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2022	02/06/22	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	29/11/21	CI
MINAPHARM Pharmaceuticals Reports Consolidated Earnings Results for the Six Months Ended June 30, 2021	30/08/21	CI
MINAPHARM Pharmaceuticals Reports Standalone Earnings Results for the Six Months Ended June 30, 2021	11/08/21	CI
MINAPHARM Pharmaceuticals Announces Consolidated Earnings Results for the Quarter Ended March 31, 2021	16/06/21	CI
ProBioGen AG and MINAPHARM Pharmaceuticals Incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company	27/05/21	CI
RDIF and Minapharm Agree to Produce over 40 Million Doses of the Sputnik V Vaccine in Egypt	22/04/21	CI
MINAPHARM Pharmaceuticals Announces Audited Consolidated Earnings Results for the Year Ended Dec. 31, 2020	31/03/21	CI
Shaheer Wafik Saad El Bardisy acquired an additional 10% stake in MINAPHARM Pharmaceuticals for approximately EGP 100 million.	25/07/20	CI
Minapharm Pharmaceuticals Reports Consolidated and Standalone Earnings Results for the First Quarter Ended March 2020	28/06/20	CI
Minapharm Pharmaceuticals Announces Consolidated and Standalone Earnings Results for the First Nine Months of 2019	28/11/19	CI
MINAPHARM Pharmaceuticals S.A.E. Reports Standalone Earnings Results for the Six Months Ended June 30, 2019	21/08/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights MINAPHARM Pharmaceuticals

Equities

MIPH

EGS380G1C011

Highlights

Filters